Other languages Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Delayed NSE India S.E. Other stock markets 05:13:13 2024-05-21 am EDT			5-day change	1st Jan Change
453.1 ^INR	+2.94%		+4.63%	+5.51%

May. 15	Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	RE
Apr. 25	Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	May. 15
Laurus Labs' Consolidated Profit Falls in Fiscal Q4	Apr. 25
Laurus Labs Limited Approves Second Interim Dividend for the Financial Year 2023-2024, Payable on or After May 17, 2024	Apr. 25
Laurus Labs Limited Approves Board Changes	Apr. 25
Laurus Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	Apr. 25
Laurus Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	Apr. 25
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%	Jan. 26
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd	Jan. 25
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 24
INDIA STOCKS-IT drives losses in Indian shares ahead of Fed policy outcome	Dec. 12
Indian shares set to open higher; focus turns to Fed policy	Dec. 12
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio	Nov. 21
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.	Nov. 19
Laurus Labs Limited Announces Resignation of Chandrakanth Chereddi as Non-Executive Director	23-10-20
Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023	23-10-20
Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-20
India's Divi's Labs Q1 profit slumps on drug pricing pressures	23-08-14
Laurus Labs' Consolidated Profit Tanks in Fiscal Q1; Shares Climb 4%	23-07-31
Laurus Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-27
Laurus Labs Pays First Tranche to Acquire Additional Stake in Cell and Gene Therapy Company	23-07-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Other languages

Filters